Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson's disease

被引:123
|
作者
Xie, Weilin [1 ]
Chung, Kenny K. K. [1 ]
机构
[1] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China
关键词
alpha-synuclein; mitochondria; neurodegeneration; Parkinson's disease; COMPLEX-I; AXONAL-TRANSPORT; FUSION; FISSION; DYSFUNCTION; INCREASES; MITOPHAGY; PATHOLOGY; MOVEMENT; PROTECTS;
D O I
10.1111/j.1471-4159.2012.07769.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
J. Neurochem. (2012) 122, 404414. Abstract Alpha-synuclein (a-syn) is a synaptic protein that mutations have been linked to Parkinsons disease (PD), a common neurodegenerative disorder that is caused by the degeneration of the dopaminergic neurons in the substantia nigra pars compacta (SNc). How a-syn can contribute to neurodegeneration in PD is not conclusive but it is agreed that mutations or excessive accumulation of a-syn can lead to the formation of a-syn oligomers or aggregates that interfere with normal cellular function and contribute to the degeneration of dopaminergic neurons. In this study, we found that a-syn can impair the normal dynamics of mitochondria and this effect is particular prominent in A53T a-syn mutant. In mice expressing A53T a-syn, age-dependent changes in both mitochondrial morphology and proteins that regulate mitochondrial fission and fusion were observed. In the cellular model of PD, we found that a-syn reduces the movement of mitochondria in both SH-SY5Y neuroblastoma and hippocampal neurons. Taken together, our study provides a new mechanism of how a-syn can contribute to PD through the impairment of normal dynamics of mitochondria.
引用
收藏
页码:404 / 414
页数:11
相关论文
共 50 条
  • [1] The Role of Alpha-Synuclein Oligomerization and Aggregation in Cellular and Animal Models of Parkinson's Disease
    Wan, Oi Wan
    Chung, Kenny K. K.
    PLOS ONE, 2012, 7 (06):
  • [2] Pathophysiology of Parkinson's disease: Mitochondria, alpha-synuclein and much more ...
    Rouaud, T.
    Corbille, A-G
    Leclair-Visonneau, L.
    de Lataillade, A. de Guilhem
    Lionnet, A.
    Preterre, C.
    Damier, P.
    Derkinderen, P.
    REVUE NEUROLOGIQUE, 2021, 177 (03) : 260 - 271
  • [3] Alpha-synuclein and Parkinson's disease
    Golbe, LI
    MOVEMENT DISORDERS, 1999, 14 (01) : 6 - 9
  • [4] Alpha-synuclein and Parkinson's disease
    C. B. Lücking
    A. Brice*
    Cellular and Molecular Life Sciences CMLS, 2000, 57 : 1894 - 1908
  • [5] Alpha-synuclein and Parkinson's disease
    Lücking, CB
    Brice, A
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (13-14) : 1894 - 1908
  • [6] Alpha-Synuclein Animal Models
    Aebischer, P.
    MOVEMENT DISORDERS, 2010, 25 : S606 - S606
  • [7] Alpha-synuclein, lipids and Parkinson's disease
    Ruiperez, Violeta
    Darios, Frederic
    Davletov, Bazbek
    PROGRESS IN LIPID RESEARCH, 2010, 49 (04) : 420 - 428
  • [8] Role of Alpha-Synuclein in Parkinson's Disease
    Link, Tina
    Maraghi, Sophie
    Reddy, Megan
    Sheth, Heli
    Stark, Kaylan
    Vijay, Varun
    FASEB JOURNAL, 2021, 35
  • [9] Alpha-synuclein spreading in Parkinson's disease
    Recasens, Ariadna
    Dehay, Benjamin
    FRONTIERS IN NEUROANATOMY, 2014, 8
  • [10] Peripheral Alpha-Synuclein and Parkinson's Disease
    Olanow, C. Warren
    Wakeman, Dustin R.
    Kordower, Jeffrey H.
    MOVEMENT DISORDERS, 2014, 29 (08) : 963 - 966